Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Go back to Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Dolby Laboratories (DLB) PT Raised to $100 at Rosenblatt

November 20, 2024 6:22 AM EST

Rosenblatt analyst Steve Frankel raised the price target on Dolby Laboratories (NYSE: DLB) to $100.00 (from $98.00) while maintaining a Buy rating.

The analyst comments "Dolby posted strong Q4 results and gave FY25 guidance that was above the Street, reflecting stabilizing demand and... More